The association between hypertension and dementia in the elderly

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Igase, Michiya ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a,b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ATENOLOL; CANDESARTAN; CHLORTALIDONE; ENALAPRIL; EPROSARTAN; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LISINOPRIL; NITRENDIPINE; PERINDOPRIL; PLACEBO; RAMIPRIL; RESERPINE; TELMISARTAN;

AGED; ALZHEIMER DISEASE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; ATTENTION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; COGNITION; COGNITIVE DEFECT; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EPISODIC MEMORY; HUMAN; HYPERTENSION; LOW DRUG DOSE; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION; TRANSIENT ISCHEMIC ATTACK;

EID: 84868286859     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/320648     Document Type: Review

References (35)

1. Lenfant C., Chobanian A. V., Jones D. W., Roccella E. J., Seventh report of the Joint National Committee on the prevention, detection, evaluation, and treatment of high blood pressure (JNC 7): resetting the hypertension sails. Hypertension 2003 41 6 1178 1179 2-s2.0-0038119700 10.1161/01.HYP.0000075790. 33892.AE (Pubitemid 36706061)
2. Vasan R. S., Beiser A., Seshadri S., Larson M. G., Kannel W. B., D'Agostino R. B., Levy D., Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. Journal of the American Medical Association 2002 287 8 1003 1010 2-s2.0-0037181148 (Pubitemid 34252058)
3. Kannel W. B., Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile. American Heart Journal 1999 138 3 S205 S210 2-s2.0-0032874915 (Pubitemid 29442329)
4. Kennelly S. P., Lawlor B. A., Kenny R. A., Blood pressure and the risk for dementia-A double edged sword. Ageing Research Reviews 2009 8 2 61 70 2-s2.0-60949108829 10.1016/j.arr.2008.11.001
5. Forette F., Seux M. L., Staessen J. A., Thijs L., Babarskiene M. R., Babeanu S., Bossini A., Fagard R., Gil-Extremera B., Laks T., Kobalava Z., Sarti C., Tuomilehto J., Vanhanen H., Webster J., Yodfat Y., Birkenhäger W. H., The prevention of dementia with antihypertensive treatment: new evidence from the systolic hypertension in Europe (syst-eur) study. Archives of Internal Medicine 2002 162 18 2046 2052 2-s2.0-0037078312 10.1001/archinte.162.18.2046 (Pubitemid 35168212)
6. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., Chalmers J., Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine 2003 163 9 1069 1075 2-s2.0-0038669268 10.1001/archinte.163.9.1069 (Pubitemid 36548935)
7. Applegate W. B., Pressel S., Wittes J., Luhr J., Shekelle R. B., Camel G. H., Greenlick M. R., Hadley E., Moye L., Perry H. M., Schron E., Wegener V., Impact of the treatment of isolated systolic hypertension on behavioral variables: results from the systolic hypertension in the elderly program. Archives of Internal Medicine 1994 154 19 2154 2160 2-s2.0-0028006802 10.1001/archinte.154.19.2154 (Pubitemid 24317261)
8. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., Olofsson B., Trenkwalder P., Zanchetti A., The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind intervention trial. Journal of Hypertension 2003 21 5 875 886 2-s2.0-0037534905 10.1097/00004872-200305000-00011 (Pubitemid 36677151)
9. Peters R., Beckett N., Forette F., Tuomilehto J., Clarke R., Ritchie C., Waldman A., Walton I., Poulter R., Ma S., Comsa M., Burch L., Fletcher A., Bulpitt C., Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. The Lancet Neurology 2008 7 8 683 689 2-s2.0-46949106968 10.1016/S1474-4422(08)70143-1
10. Chen J. H., Lin K. P., Chen Y. C., Risk factors for dementia. Journal of the Formosan Medical Association 2009 108 10 754 764 2-s2.0-74049086128
11. Gorelick P. B., Risk factors for vascular dementia and Alzheimer disease. Stroke 2004 35 11 2620 2622 2-s2.0-7644223380 10.1161/01.STR.0000143318.70292. 47 (Pubitemid 39458352)
12. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J., Blood pressure, stroke, and coronary heart diseasepart 1: prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990 335 8692 765 774 2-s2.0-0025234906 10.1016/0140-6736(90)90878-9 (Pubitemid 20106689)
13. Knopman D., Boland L. L., Mosley T., Howard G., Liao D., Szklo M., McGovern P., Folsom A. R., Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001 56 1 42 48 (Pubitemid 32059650)
14. Kivipelto M., Helkala E. L., Hänninen T., Laakso M. P., Hallikainen M., Alhainen K., Soininen H., Tuomilehto J., Nissinen A., Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001 56 12 1683 1689 2-s2.0-0035954333 (Pubitemid 32574567)
15. Reitz C., Tang M. X., Manly J., Mayeux R., Luchsinger J. A., Hypertension and the risk of mild cognitive impairment. Archives of Neurology 2007 64 12 1734 1740 2-s2.0-37149016808 10.1001/archneur.64.12.1734 (Pubitemid 350254935)
16. Launer L. J., Ross G. W., Petrovitch H., Masaki K., Foley D., White L. R., Havlik R. J., Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiology of Aging 2000 21 1 49 55 2-s2.0-0034594441 10.1016/S0197-4580(00)00096-8 (Pubitemid 30224785)
17. Yamada M., Mimori Y., Kasagi F., Miyachi T., Ohshita T., Sasaki H., Incidence and risks of dementia in Japanese women: radiation Effects Research Foundation Adult Health Study. Journal of the Neurological Sciences 2009 283 1-2 57 61 2-s2.0-67650138196 10.1016/j.jns.2009.02.338
18. Birns J., Kalra L., Cognitive function and hypertension. Journal of Human Hypertension 2009 23 2 86 96 2-s2.0-58549107564 10.1038/jhh.2008.80
19. Qiu C., Winblad B., Fratiglioni L., The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurology 2005 4 8 487 499 2-s2.0-22144451172 10.1016/S1474-4422(05)70141-1 (Pubitemid 40982459)
20. Ninomiya T., nino@intmed2.med.kyushu-u.ac.jp Ohara T., Hirakawa Y., Yoshida D., Doi Y., Hata J., Kanba S., Iwaki T., Kiyohara Y., Midlife and late-life blood pressure and dementia in japanese elderly: the hisayama study. Hypertension 2011 58 1 22 28 10.1161/HYPERTENSIONAHA.110.163055
21. Li J., Wang Y. J., yanjiangwang@tmmu.edu.cn Zhang M., Xu Z. Q., Gao C. Y., Fang C. Q., Yan J. C., Zhou H. D., zhouhuadong163@163.com Chongqing Ageing Study GroupVascular risk factors promote conversion from mild cognitive impairment to Alzheimer disease. Neurology 2011 76 17 1485 1491 10.1212/WNL.0b013e318217e7a4
22. Peters R., Beckett N., Forette F., Tuomilehto J., Clarke R., Ritchie C., Waldman A., Walton I., Poulter R., Ma S., Comsa M., Burch L., Fletcher A., Bulpitt C., Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. The Lancet Neurology 2008 7 8 683 689 2-s2.0-46949106968 10.1016/S1474-4422(08)70143-1
23. McGuinness B., Todd S., Passmore P., Bullock R., Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database of Systematic Reviews 2009 2 2-s2.0-74949089743 10.1002/14651858.CD004034.pub3 CD004034
24. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., MacMahon S., Chalmers J., Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine 2003 163 9 1069 1075 10.1001/archinte. 163.9.1069 (Pubitemid 36548935)
25. Turnbull F., Neal B., Pfeffer M., Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system. Journal of Hypertension 2007 25 5 951 958 2-s2.0-34147116836 10.1097/HJH. 0b013e3280bad9b4 (Pubitemid 46573113)
26. Krikov M., Thone-Reineke C., Müller S., Villringer A., Unger T., Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats. Journal of Hypertension 2008 26 3 544 552 2-s2.0-39849108925 10.1097/HJH.0b013e3282f2dac9 (Pubitemid 351317265)
27. Fournier A., Messerli F. H., Achard J. M., Fernandez L., Cerebroprotection mediated by angiotensin II: a hypothesis supported by recent randomized clinical trials. Journal of the American College of Cardiology 2004 43 8 1343 1347 2-s2.0-1942484955 10.1016/j.jacc.2003.10.060 (Pubitemid 38496335)
28. Boutitie F., Oprisiu R., Achard J. M., Mazouz H., Wang J., Messerli F. H., Gueyffier F., Fournier A., Does a change in angiotensin II formation caused by antihypertensive drugs affect the risk of stroke? A meta-analysis of trials according to treatment with potentially different effects on angiotensin II. Journal of Hypertension 2007 25 8 1543 1553 2-s2.0-34447301224 10.1097/HJH.0b013e32814a5ae5 (Pubitemid 47056556)
29. The ONTARGET Investigators, Telmisartan, ramipril, or both in patients at high risk for vascular events. The New England Journal of Medicine 2008 358 15 1547 1559 2-s2.0-42049107348 10.1056/NEJMoa0801317 (Pubitemid 351522739)
30. The Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators, Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial. The Lancet 2008 372 9644 1174 1183
31. Diener H. C., Sacco R. L., Yusuf S., Cotton D., Ôunpuu S., Lawton W. A., Palesch Y., Martin R. H., Albers G. W., Bath P., Bornstein N., Chan B. P., Chen S. T., Cunha L., Dahlöf B., De Keyser J., Donnan G. A., Estol C., Gorelick P., Gu V., Hermansson K., Hilbrich L., Kaste M., Lu C., Machnig T., Pais P., Roberts R., Skvortsova V., Teal P., Toni D., VanderMaelen C., Voigt T., Weber M., Yoon B. W., Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. The Lancet Neurology 2008 7 10 875 884 2-s2.0-51449085994 10.1016/S1474-4422(08)70198-4
32. Fogari R., Mugellini A., Zoppi A., Lazzari P., Destro M., Rinaldi A., Preti P., Effect of telmisartan/hydrochlorothiazide vs lisinopril/ hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients. Journal of Human Hypertension 2006 20 3 177 185 2-s2.0-33744909553
33. Li N. C., Lee A., Whitmer R. A., Kivipelto M., Lawler E., Kazis L. E., Wolozin B., Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. British Medical Journal 2010 340 b5465 2-s2.0-74249110813 10.1136/bmj.b5465
34. Tsukuda K., Mogi M., Iwanami J., Min L. J., Sakata A., Jing F., Iwai M., Horiuchi M., Cognitive deficit in amyloid- β -injected mice was improved by pretreatment with a low dose of telmisartan partly because of peroxisome proliferator-activated receptor- γ activation. Hypertension 2009 54 4 782 787 2-s2.0-70349682174 10.1161/HYPERTENSIONAHA.109.136879
35. Wang J., Ho L., Chen L., Zhao Z., Zhao W., Qian X., Humala N., Seror I., Bartholomew S., Rosendorff C., Pasinetti G. M., Valsartan lowers brain β -amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease. Journal of Clinical Investigation 2007 117 11 3393 3402 2-s2.0-36049002393 10.1172/JCI31547 (Pubitemid 350096995)